News & Announcements

AdvocureNF2 Funds NF2 Research for 2015 – FINAL

With over $100K monies raised from The 10th Annual Halloween Bash in 2014, proceeds went to re-support the NF2 research projects of 2014. Their studies had shown much improvement and direction to find a cure for NF2. These projects were: Synodos CTF Cristina Fernadez-Vale, Pharmacokinetic Studies for Drugs of Interest in Treatment of Neurofibromatosis Type… Continue Reading →

Cindy Baxter Reese, AdvocureNF2 Treasurer and NF2 Advocate

AdvocureNF2 is saddened to announce that Cindy Reese, AdvocureNF2’s longtime treasurer, passed away on January 28, 2015 due to complications of NF2. She gave graciously of her time to consistently provide a high degree of professionalism regarding AdvocureNF2’s financial matters to meet deadlines. She was committed in supporting research to find a cure for NF2.… Continue Reading →

NF2 Research and Media News in 2014

‘Open science’ could open doors for pharma Posted:Wed, 24 Dec 2014 09:30:00 EST When Johnson & Johnson agreed to make its clinical trial data available to outside parties through the Yale School of Medicine, proponents billed it as a victory for transparency in drug research. Those same advocates of so-called “open science” hope it will… Continue Reading →

2014 Halloween Bash Raises Funds for Research

AdvocureNF2 is thrilled to announce that this year’s Halloween Bash brought in $25,000! Additionally, Roland Thoms’ family will once again match the donation amount plus more with $50,000! A special thank you to Roland Thoms, the sponsors and guests for their extraordinary efforts to raise much needed funds for NF2. The Halloween Bash is the… Continue Reading →

Advocure Funds Five NF2 Research Projects for 2014

With the success of Roland Thoms’ 9th Annual Halloween Bash in 2013 – an annual event that takes place in North and South California, proceeds raised went to five different NF2 research projects this year. The projects supported this year are: Synodos A new Children’s Tumor Foundation (CTF.org) program designed to accelerate treatments for NF2.… Continue Reading →